Growth Strategy for a Major European Animal Nutrition Business with Strategic Expansion into Mexican Animal Feed Market

Growth Strategy for a Major European Animal Nutrition Business with Strategic Expansion into Mexican Animal Feed Market

August 10, 2017
August 10, 2017

Share

AMR (acquired by Stax in 2022) assisted Provimi in making a major strategic move into the Mexican animal feed market.


Client and project overview

Provimi, a major European animal nutrition business, wanted to build a presence in the Mexican market and had identified a potential acquisition target. AMR was asked to provide input on the achievability of the business plan in light of numerous risk factors.


Key questions

  • What is the structure of the Mexican animal feed market and how is it changing (including industrialization)?
  • How have external factors impacted the target’s performance?
  • What are the target’s sources of competitive advantage and how sustainable are there?


Highlights of methodology

  • Developed a sophisticated understanding of the external factors influencing the target’s performance, including underlying demand, industrialization, macro shocks, regional variation and competition
  • We combined this with a thorough review of the target’s internal data (including pricing) and customer base


Results

  • Our work proved critical to allowing the deal to go ahead, based on the key finding that recent volatility in the target’s performance was caused by one-off, external factors and the underlying performance was highly stable
  • Our analysis of customer preferences also identified clear value-creation potential
  • Based on clear recommendations from AMR, the business was able to perform significantly ahead of budget in year one


“The sale of Provimi is the culmination of a four-year project to reshape the business and maximize shareholder value. AMR played a critical role in supporting Provimi as we realized this vision, and helped provide valuable support in the course of a smooth and well-run transaction.” (Provimi)

Read More

By Rob Larson, Jordan Abrams February 17, 2026
A recap of Grant Thornton Stax and Raymond James’ healthcare breakfast on PE investment opportunities across the pharma tech ecosystem.
How AI is Reshaping Vertical SaaS
By Kelsey Chisholm & Palash Misra February 12, 2026
AI is driving a bifurcation between surface-layer productivity tools and core operational platforms within vertical software. Learn how Ai is reshaping vertical SaaS here.
Vault Top 50: Four Years Running
February 11, 2026
For four straight years, Grant Thornton Stax has earned a spot on the Vault Consulting Top 50 list of the best consulting firms to work for in North America. Read more here.
Grant Thornton Stax Advises Alma on its Acquisition by Spring Health​
February 3, 2026
Grant Thornton Stax supported Alma, a membership-based platform that aids mental health clinicians in building thriving private practices, on its recent acquisition by Spring Health. Read more.
Grant Thornton Stax Announces Winter 2026 Promotions
January 30, 2026
Grant Thornton Stax is pleased to announce our 2026 winter promotions. Click to learn more.
Stax Consultant Spotlight: Chris Flynn
January 30, 2026
Grant Thornton Stax Consultant Chris Flynn sits down for a Q&A to share his experience and insights from his tenure with our firm. Read the full interview here.
Show More